Similarly, in thyroid cancer cells, E2 and genistein could activate the MAPK pathway via GPR30, as a result to stimulate c-fos expression and growth response (Vivacqua et al., 2006). The gene discussed is GPER1; the disease is thyroid gland carcinoma.